Healthcare provider profile · identity verified

Benjamin Hardy Crenshaw, MD

Family Practice · COLUMBIA, MO · NPI 1477580967

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	374	99
Levothyroxine Sodium	Levothyroxine Sodium	293	65
Lisinopril	Lisinopril	257	71
Gabapentin	Gabapentin	215	53
Amlodipine Besylate	Amlodipine Besylate	200	44
Mirtazapine	Mirtazapine	198	19
Sertraline Hcl	Sertraline Hcl	188	29
Omeprazole	Omeprazole	182	42
Tamsulosin Hcl	Tamsulosin Hcl	178	42
Losartan Potassium	Losartan Potassium	160	40
Metformin Hcl	Metformin Hcl	142	31
Pantoprazole Sodium	Pantoprazole Sodium	126	26
Hydrochlorothiazide	Hydrochlorothiazide	124	36
Fluticasone Propionate	Fluticasone Propionate	116	29
Finasteride	Finasteride	115	21
Eliquis	Apixaban	100	25
Trazodone Hcl	Trazodone Hcl	99	13
Metoprolol Succinate	Metoprolol Succinate	94	18
Rosuvastatin Calcium	Rosuvastatin Calcium	92	26
Tramadol Hcl	Tramadol Hcl	92	23
Furosemide	Furosemide	88	24
Metoprolol Tartrate	Metoprolol Tartrate	87	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	14
Duloxetine Hcl	Duloxetine Hcl	79	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	77	14
Tizanidine Hcl	Tizanidine Hcl	74	suppressed
Pravastatin Sodium	Pravastatin Sodium	73	18
Jardiance	Empagliflozin	72	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	suppressed
Warfarin Sodium	Warfarin Sodium	69	suppressed
Atenolol	Atenolol	68	12
Clonazepam	Clonazepam	68	12
Simvastatin	Simvastatin	67	20
Metformin Hcl Er	Metformin Hcl	63	21
Meloxicam	Meloxicam	62	20
Montelukast Sodium	Montelukast Sodium	62	15
Oxycodone Hcl	Oxycodone Hcl	62	15
Spironolactone	Spironolactone	62	12
Clopidogrel	Clopidogrel Bisulfate	61	11
Ozempic	Semaglutide	61	suppressed
Mounjaro	Tirzepatide	60	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	56	13
Allopurinol	Allopurinol	54	15
Memantine Hcl	Memantine Hcl	54	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	52	16
Carvedilol	Carvedilol	51	15
Celecoxib	Celecoxib	50	11
Potassium Chloride	Potassium Chloride	47	17
Amitriptyline Hcl	Amitriptyline Hcl	46	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	11
Fentanyl	Fentanyl	45	suppressed
Bupropion Xl	Bupropion Hcl	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	42	17
Glipizide Er	Glipizide	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Trulicity	Dulaglutide	39	suppressed
Baclofen	Baclofen	38	suppressed
Ezetimibe	Ezetimibe	37	suppressed
Lorazepam	Lorazepam	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	12
Lovastatin	Lovastatin	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	11
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Bupropion Hcl	Bupropion Hcl	31	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	30	29
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	12
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Valsartan	Valsartan	29	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Estradiol	Estradiol	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Famotidine	Famotidine	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Glipizide	Glipizide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	19	suppressed
Naproxen	Naproxen	19	suppressed
Techlite Pen Needle	Pen Needle, Diabetic	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Risperidone	Risperidone	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Topiramate	Topiramate	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Diazepam	Diazepam	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Prednisone	Prednisone	15	12
Testosterone	Testosterone	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	12	12
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error